Dr Reddy’s faces post-lenalidomide growth challenge, says Prasad
Dr Reddy's Laboratories Ltd reported a nearly 70% fall in first-quarter profit, with North American sales dropping by more than a third, after a botched scale-up of semaglutide, the active ingredient in…
